A new study has found that people suffering from type 2 diabetes but who do not have cardiovascular disease have a greater chance of recurrent stroke and cardiovascular events than those without the condition.
Researcher Alfred Callahan commented “This increased risk is attenuated by intensive lipid lowering not only in diabetics but also those with metabolic syndrome as well as those without type 2 diabetes or metabolic syndrome.”
The research, carried out by scientists in the United States and published in the Archives of Neurology, also found that statins seem to reduce the risk in both groups and by about the same amount as those without these conditions.
The study, which used data from the Stroke Prevention by Aggressive Reduction of Cholesterol Levels (SPARCL) trial, also noted “Although the possibility of variation in the benefit of statin treatment in subjects with or without type 2 diabetes or MetS [metabolic syndrome] cannot be excluded by this analysis, there was no evidence of a difference in treatment effect.”
The SPARCL trial involved 4,731 patients who have had a stroke or a transient ischemic attack (TIA), known as a mini stroke, and focused on the effect of statins on secondary stroke prevention in people with type 2 diabetes or metabolic syndrome.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…